USPTO trademark

AVNZ

RegisteredUSPTOWord markClass 5

"AVNZ" is a word mark owned by Mercury Pharma Group Limited, filed at the USPTO on May 11, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Mercury Pharma Group Limited portfolioGet this data via the API
Official USPTO record
AVNZ trademark as filed
As filed with the USPTO
Status
Registered
Since September 5, 2023
Filed
May 11, 2022
Registered
September 5, 2023
Priority date
April 8, 2022
Claimed from United Kingdom
Application no.
97405274
Registration no.
7154374
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns AVNZ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Mercury Pharma Group Limited

London, United Kingdom

603 trademarks in the portfolioView company

Representative

Meghna Prasad

Baker Botts L.L.P.

Goods and services

What the mark covers

The products and services AVNZ is filed for, grouped by Nice class.

  • A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Law office publication review completed
  7. Approved for pub - principal register
  8. Examiner's amendment entered
  9. Notification of examiners amendment e-mailed
  10. Examiners amendment e-mailed

10 earlier steps on the official record.

FAQ

About AVNZ

Who owns the trademark "AVNZ"?

The USPTO trademark "AVNZ" (application 97405274) is owned by Mercury Pharma Group Limited.

What is the status of "AVNZ"?

Its status at the USPTO is: registered.

When was "AVNZ" registered?

It was registered on September 5, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AVNZ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a88-bf77-7311-a42b-eea8f73cd2cb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a88-bf77-7311-a42b-eea8f73cd2cb",
  "object": "trademark",
  "mark_text": "AVNZ",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97405274",
  "filing_date": "2022-05-11",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Mercury Pharma Group Limited",
      "entity_id": "ent_019ebc1c-43cc-7756-a067-ba4f307e3583"
    }
  ]
}